Viral latency--the papillomavirus model
- PMID: 11761260
Viral latency--the papillomavirus model
Abstract
To investigate the prevalence and the natural history of human papillomavirus infections, we monitored HPV DNA shedding as a consequence of immunosuppression, with the expectation that latent viral infections would reactivate and become detectable. The study populations consisted of women who were in end-stage renal failure, those who ultimately received kidney transplantations, and those who had HIV/AIDS with various degrees of immune depression at entry. For each woman, cervico-vaginal lavage to sample viral shedding from the lower genital tract was performed at approximately six month intervals, and the cohorts have been followed since 1996. Nested polymerase chain reaction amplification of papillomavirus DNA using novel pairs of primers was followed by diagnostic restriction endonuclease cleavage or by DNA sequencing. This strategy is particularly capable of identifying single and multiple infections and determining the genotypes of any viruses present. Of the 225 women in the HIV cohort, 177 (79%) were HPV-positive and 111 (49%) shed from two up to eight different HPV types over the course of the survey. Thirty-five different mucosotropic HPV types, virtually all that have ever been described worldwide, were isolated from these 225 women, and nine additional new (provisional) types were discovered. As is always the case, HPV-6 was very common. However, all the other frequently detected HPV types (45, 52, 53, 54, 58, 74) were more prevalent than the types typically reported forthe general population (HPV-11, 16, 18, 31, 33, 35). Notably, the 14 members of the A3 phylogenetic subgroup (HPV-61, 62, 72, 81, 83, 84, and all the new types) were by far the most frequently observed viral types in the AIDS cohort. The HPV prevalence in the cohorts of kidney transplantation candidates and recipients was only slightly lower than that in the AIDS cohort. We conclude that HPV infections are extraordinarily common and are normally held in a sub-clinical state by functional immune systems, but can be reactivated by immunosuppressive conditions. The question of how so many distinct types persist in the human population and can be repeatedly isolated from specimens collected around the world raises complex issues concerning the nature of viral transmission, reproduction, shedding, and mutational drift. These molecular epidemiological observations signal the likelihood that HPV is part of the commensal microflora of human epithelia. Their prevalence elicits a caution that latent HPV DNA may be present in primary human epithelial tissues.
Similar articles
-
Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.Int J STD AIDS. 2003 Jun;14(6):417-25. doi: 10.1258/095646203765371321. Int J STD AIDS. 2003. PMID: 12816671
-
Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.J Med Virol. 2008 Oct;80(10):1814-23. doi: 10.1002/jmv.21282. J Med Virol. 2008. PMID: 18712836
-
Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women.Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):283-8. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15668510
-
Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.Scand J Infect Dis Suppl. 2009;107:3-32. doi: 10.1080/00365540902887730. Scand J Infect Dis Suppl. 2009. PMID: 19408160 Review.
-
The natural history of human papillomavirus infections of the mucosal epithelia.APMIS. 2010 Jun;118(6-7):422-49. doi: 10.1111/j.1600-0463.2010.02625.x. APMIS. 2010. PMID: 20553526 Review.
Cited by
-
The burden of human papillomavirus infections and related diseases in sub-saharan Africa.Vaccine. 2013 Dec 29;31 Suppl 5(0 5):F32-46. doi: 10.1016/j.vaccine.2012.07.092. Vaccine. 2013. PMID: 24331746 Free PMC article. Review.
-
Papillomavirus-specific CD4+ T cells exhibit reduced STAT-5 signaling and altered cytokine profiles in patients with recurrent respiratory papillomatosis.J Immunol. 2011 Jun 1;186(11):6633-40. doi: 10.4049/jimmunol.1004181. Epub 2011 Apr 29. J Immunol. 2011. PMID: 21531896 Free PMC article.
-
Extralaryngeal HPV infections in male patients with adult-onset laryngeal papillomatosis.Eur Arch Otorhinolaryngol. 2005 Sep;262(9):708-12. doi: 10.1007/s00405-004-0811-3. Epub 2005 Aug 24. Eur Arch Otorhinolaryngol. 2005. PMID: 16133466
-
HPV disease transmission protection and control.Microb Cell. 2016 Sep 5;3(9):476-490. doi: 10.15698/mic2016.09.530. Microb Cell. 2016. PMID: 28357382 Free PMC article. Review.
-
Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11.APMIS. 2010 Jun;118(6-7):455-70. doi: 10.1111/j.1600-0463.2010.02617.x. APMIS. 2010. PMID: 20553528 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Research Materials